Portola Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Asset
Portola Pharmaceuticals, Inc. reported Increase (Decrease) in Contract with Customer, Asset of -$375.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2020-03-31 was -$375.00K.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2019-12-31 was -$5.00K, a 162.50% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2019-09-30 was -$1.01M, a 129.78% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2019-06-30 was -$1.52M, a 183.12% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for fiscal 2019 was -$6.10M, a 291.37% decline from fiscal 2018.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for fiscal 2018 was $3.19M.
- Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, asset for fiscal 2017 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$375.00K 10-Q · filed 2020-05-11 | -$380.00K derived: sum of 2 quarters · filed 2020-05-11 | -$1.39M derived: sum of 3 quarters · filed 2020-05-11 | -$2.91M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$1.01M derived: sum of 2 quarters · filed 2020-02-28 | -$2.53M derived: sum of 3 quarters · filed 2020-02-28 | -$6.10M 10-K · filed 2020-02-28 |
| 2019-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$2.53M derived: sum of 2 quarters · filed 2019-11-05 | -$6.09M 10-Q · filed 2019-11-05 | -$6.08M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$5.08M 10-Q · filed 2019-08-07 | -$5.08M derived: sum of 3 quarters · filed 2020-05-11 | -$1.70M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$3.56M 10-Q · filed 2020-05-11 | -$3.56M derived: sum of 2 quarters · filed 2020-05-11 | -$174.00K derived: sum of 3 quarters · filed 2020-05-11 | $1.66M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.39M derived: sum of 2 quarters · filed 2020-02-28 | $5.22M derived: sum of 3 quarters · filed 2020-02-28 | $3.19M 10-K · filed 2020-02-28 |
| 2018-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.21M derived: sum of 2 quarters · filed 2019-11-05 | $3.18M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$203.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$2.03M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |